Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

66.7%

2 terminated/withdrawn out of 3 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01826630Not ApplicableTerminated

A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema

Role: collaborator

NCT03534388Not ApplicableWithdrawn

A Feasibility Study to Evaluate Skin Cleansing With a Sodium Hypochlorite Wash

Role: lead

NCT01714245Completed

A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients

Role: lead

All 3 trials loaded